AnyGen Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AnyGen Co Ltd with three other
pharmaceutical manufacturers in Asia:
Piramal Phytocare Ltd
of India
(2018
sales of 238.14 million Indian Rupees [US$3.35 million]
),
Genotech Corp
(3.11 billion Korean Won [US$2.67 million]
), and
Nibec
(5.21 billion Korean Won [US$4.48 million]
of which 100%
was Biomaterials Convergence Tech&Drug Deliv).
Sales Analysis.
AnyGen Co Ltd reported sales of 4.11 billion Korean Won (US$3.54 million)
for the
year ending
December of 2018.
This
represents
a
decrease of 9.6%
versus 2017, when the company's sales were 4.55 billion Korean Won.
The sales level in 2018 was fairly close to the level five years ago: in 2013, AnyGen Co Ltd had sales
of 4.01 billion Korean Won.